Drugs Made In America Acquisition Corp. Units (DMAAU) Stock Price
DMAAUStock
$10.79
Market Cap$314.76M
P/E43.77x
PEG Ratio—
Div yield—
Beta-0.01
DMAAU Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-7.98%
Price vs S&P 500 (4W)-2.30%
VGM Score57.55
P/E Ratio (Annual)43.77x
Industry Peers — Blank Checks / SPACs(909)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DMAAUDrugs Made In America Acquisition Corp. Units | — | C | C | $10.79 |
| BXBLBOXABL, Inc. Common stock | C | B | D | $4.27 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.15 |
| CXIIChurchill Capital Corp XII Class A Ordinary Shares | — | — | F | $10.82 |
| BCSSBain Capital GSS Investment Corp. | — | — | B | $10.28 |
| EVACEQV Ventures Acquisition Corp. II | — | — | B | $10.27 |
| CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | — | — | D | $10.38 |
| AEXAAmerican Exceptionalism Acquisition Corp. A | — | — | B | $11.49 |
| DBCAD. Boral Acquisition I Corp. Class A Ordinary Shares | — | — | D | $10.00 |
| GHXIGores Holdings XI, Inc. Class A Ordinary Shares | — | — | D | $10.04 |
| RFAIURF Acquisition Corp II Unit | D | F | A | $52.94 |
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify, acquire, and operate a business in the pharmaceutical or healthcare sector. The company seeks to combine with a domestic drug manufacturer or related healthcare enterprise through a merger or acquisition. It provides investors with exposure to the U.S. pharmaceutical industry through a structured business combination transaction.